Switch to: References

Add citations

You must login to add citations.
  1. Rescuing the Duty to Rescue.Tina Rulli & Joseph Millum - 2014 - Journal of Medical Ethics:1-5.
    Clinicians and health researchers frequently encounter opportunities to rescue people. Rescue cases can generate a moral duty to aid those in peril. As such, bioethicists have leveraged a duty to rescue for a variety of purposes. Yet, despite its broad application, the duty to rescue is under-analyzed. In this paper, we assess the state of theorizing about the duty to rescue. There are large gaps in bioethicists’ understanding of the force, scope, and justification of the two most cited duties to (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • For the Sake of Justice: Should We Prioritize Rare Diseases?Niklas Juth - 2017 - Health Care Analysis 25 (1):1-20.
    This article is about the justifiability of accepting worse cost effectiveness for orphan drugs, that is, treatments for rare diseases, in a publicly financed health care system. Recently, three arguments have been presented that may be used in favour of exceptionally advantageous economic terms for orphan drugs. These arguments share the common feature of all referring to considerations of justice or fairness: the argument of the irrelevance of group size, the argument from the principle of need, and the argument of (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  • Health Care Organizations and the Power of Procedure.Emily A. Largent - 2016 - American Journal of Bioethics 16 (1):51-53.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • What Is the Value of Three-Parent IVF?Tina Rulli - 2016 - Hastings Center Report 46 (4):38-47.
    In February 2016, the Institute of Medicine released a report, commissioned by the United States Food and Drug Administration, on the ethical and social-policy implications of so-called three-parent in vitro fertilization. The IOM endorses commencement of clinical trials on three-parent IVF, subject to some initial limitations. Also called mitochondrial replacement or transfer, three-parent IVF is an intervention comprising two distinct procedures in which the genetic materials of three people—the DNA of the father and mother and the mitochondrial DNA of an (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   7 citations